Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior

Psychopharmacology

Volumn 218, Issue 4, 2011, Pages 749-759

  De Carolis, Lorenza ^a   Schepisi, Chiara ^a   Milella, Michele S ^a   Nencini, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aripiprazole; Clomipramine; Contrafreeloading; Haloperidol; Obsessive compulsive disorder; Quinpirole

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; HALOPERIDOL; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPULSION; CONTRAFREELOADING; CONTROLLED STUDY; DECISION MAKING; DISEASE MODEL; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; FLUID INTAKE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CLOMIPRAMINE; COMPULSIVE BEHAVIOR; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING BEHAVIOR; HALOPERIDOL; MALE; PIPERAZINES; QUINOLONES; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 82955213049     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2372-7     Document Type: Article

References (53)

1. D Amato MS Milella A Badiani P Nencini 2006 Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats Behav Brain Res 172 1 13 16677719 10.1016/j.bbr.2006.03.038 1:CAS:528:DC%2BD28XntVyks7w%3D (Pubitemid 44037810)
2. D Amato MS Milella A Badiani P Nencini 2007 Compulsive-like effects of quinpirole on drinking behavior in rats are inhibited by substituting ethanol for water Behav Brain Res 177 340 346 17157931 10.1016/j.bbr.2006.11.016 1:CAS:528:DC%2BD2sXhtVChs7w%3D (Pubitemid 46149902)
3. D Amato MA Stasi F Borsini P Nencini 2008 Haloperidol both prevents and reverses quinpirole-induced nonregulatory water intake, a putative animal model of psychogenic polydipsia Psychopharmacology 200 157 165 18597076 10.1007/s00213-008-1229-1 1:CAS:528:DC%2BD1cXhtFOjsLfK
4. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th edn., revised). Washington DC: Author
5. P Bäckström TJ Etelälahti P Hyytiä 2011 Attenuation of reinforcing and psychomotor stimulant effects of amphetamine by aripiprazole Addict Biol 1 55 63 10.1111/j.1369-1600.2010.00223.x
6. V Boulougouris A Castañe TW Robbins 2009 Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behaviour Psychopharmacology 202 611 620 18836703 10.1007/s00213-008-1341-2 1:CAS:528:DC%2BD1cXht1aisLfF
7. NA Bratcher V Farmer-Dougan JD Dougan BA Heidenreich PA Garris 2005 The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists J Exp Anal Behav 3 371 399 10.1901/jeab.2005.82-04 (Pubitemid 43348207)
8. KD Burris TF Molski C Xu E Ryan K Tottori T Kikuchi FD Yocca PB Molinoff 2002 Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors J Pharmacol Exp Ther 302 381 389 12065741 10.1124/jpet.102.033175 1:CAS:528:DC%2BD38Xlt1SnsLY%3D (Pubitemid 34680462)
9. P Cavedini G Riboldi A D'Annucci P Belotti M Cisima L Bellodi 2002 Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes Neuropsychologia 40 205 211 11640942 10.1016/S0028-3932(01)00077-X 1:STN:280:DC%2BD3MrmtlGmsQ%3D%3D (Pubitemid 32964674)
10. I Cioli A Caricati P Nencini 2000 Quinpirole- and amphetamine-induced hyperdipsia: influence of fluid palatability and behavioral cost Behav Brain Res 109 9 18 10699653 10.1016/S0166-4328(99)00155-2 1:CAS:528:DC%2BD3cXhsVaisrg%3D (Pubitemid 30107869)
11. L Dahan H Husum O Mnie-Filali J Arnt P Hertel N Haddjeri 2009 Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behavior J Psychopharmacol 23 177 189 18515444 10.1177/ 0269881108089586 1:CAS:528:DC%2BD1MXksVyjtrY%3D
12. B Dell'Osso G Nestadt A Allen E Hollander 2006 Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: a critical review J Clin Psychiatry 67 600 610 16669725 10.4088/JCP.v67n0411 (Pubitemid 43764237)
13. F Denk ME Walton KA Jennings T Sharp MFS Rushworth DM Bannerman 2005 Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort Psychopharmacology 179 587 596 15864561 10.1007/s00213-004-2059-4 1:CAS:528:DC%2BD2MXjslOrsrw%3D (Pubitemid 40674759)
14. DM Eagle C Baunez 2010 Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition Neurosci Biobehav Rev 34 50 72 19615404 10.1016/j.neubiorev.2009.07. 003
15. N Egashira R Okuno M Matsushita M Abe K Mishima K Iwasaki R Nishimura R Oishi M Fujiwara 2008 Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms Eur J Pharmacol 592 103 108 18644366 10.1016/j.ejphar.2008.06.100 1:CAS:528:DC%2BD1cXhtVegu7nK
16. D Eilam H Szechtman 2005 Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals CNS Spectr 10 191 202 15744221 (Pubitemid 40489289)
17. KD Ersche JP Roiser TW Robbins BJ Sahakian 2008 Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans Psychopharmacology 197 421 423 18214445 10.1007/s00213-007-1051-1 1:CAS:528:DC%2BD1cXjsFOnu70%3D
18. A Etievant C Betry J Arnt N Haddjeri 2009 Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation Neurosci Lett 460 82 86 19450663 10.1016/j.neulet.2009. 05.035 1:CAS:528:DC%2BD1MXmvF2hs7w%3D
19. A Faure P Leblanc-Veyrac N El Massioui 2010 Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism Neuroscience 168 477 486 20362642 10.1016/j.neuroscience. 2010.03.047 1:CAS:528:DC%2BC3cXmtFCiur0%3D
20. LK Fellows MJ Farah 2003 Ventromedial frontal cortex mediates affective shifting in humans: evidence from a reversal learning paradigm Brain 126 1830 1837 12821528 10.1093/brain/awg180 (Pubitemid 36917342)
21. A Fernandez-Guasti RE Ulloa H Nicolini 2003 Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder Psychoparmacology 166 3 195 201 1:CAS:528:DC%2BD3sXitFGmt70%3D (Pubitemid 36384764)
22. WK Goodman LH Price PL Delgado J Palumbo JH Krystal LM Nagy SA Rasmussen GR Heninger DS Charney 1990 Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine Arch Gen Psychiatry 47 577 585 2112374 1:CAS:528: DyaK3MXhslCitA%3D%3D (Pubitemid 20189970)
23. WK Goodman CJ McDougle LH Price MA Riddle DL Pauls JF Leckman 1990 Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry 51 S36 S43
24. DM Haluk SB Floresco 2009 Ventral striatal dopamine modulation of different forms of behavioral flexibility Neuropsychopharmacology 34 2041 2052 19262467 10.1038/npp.2009.21 1:CAS:528:DC%2BD1MXnsFSisr4%3D
25. T Hirose Y Uwahodo S Yamanada T Miwa T Kikuchi H Kitawaga KD Burris AC Altar T Nabeshima 2004 Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile J Psychopharmacol 18 375 383 15358981 10.1177/026988110401800308 1:CAS:528:DC%2BD2cXpsl2nu7Y%3D (Pubitemid 39382565)
26. IR Inglis NJK Ferguson 1986 Starlings search for food rather than eat freely available, identical food Anim Behav 34 614 617 10.1016/S0003-3472(86) 80136-1
27. K Ishiwari SM Weber S Mingote M Correa JD Salamone 2004 Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements Behav Brain Res 151 83 91 15084424 10.1016/j.bbr.2003.08.007 1:CAS:528:DC%2BD2cXjtFalt78%3D (Pubitemid 38501431)
28. ED Jensen 1963 Preference for bar pressing over "free-loading" as a function of unrewarded presses J Exp Psychol 65 451 454 10.1037/h0049174
29. E Jerlhag 2008 The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice Alcohol 42 123 127 18358991 10.1016/j.alcohol.2007.11.004 1:CAS:528:DC%2BD1cXjs1WgtLc%3D (Pubitemid 351389735)
30. D Joel 2006 Current animal models of obsessive compulsive disorder: a critical review Prog Neuropsychopharmacol Biol Psychiatry 30 374 388 16457927 10.1016/j.pnpbp.2005.11.006
31. D Joel A Avisar 2001 Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder? Behav Brain Res 123 77 87 11377731 10.1016/S0166-4328(01)00201-7 1:STN:280:DC%2BD3M3pslSnsQ%3D%3D (Pubitemid 32506825)
32. T Kenakin 2007 Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72 1393 1401 17901198 10.1124/mol.107.040352 1:CAS:528:DC%2BD2sXhsVahu7fK (Pubitemid 350146075)
33. T Kikuchi K Tottori Y Uwahodo T Hirose T Miwa Y Oshiro S Morita 1995 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H) -quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity J Pharmacol Exp Ther 274 329 336 7616416 1:CAS:528:DyaK2MXntVWlt7c%3D
34. B Koener S Goursaud M Van De Stadt AG Calas AP Jeanjean JM Maloteaux E Hermans 2010 Pharmacological blockade of dopamine D(2) receptors by aripiprazole is not associated with striatal sensitization Naunyn Schmiedebergs Arch Pharmacol 383 65 77 10.1007/s00210-010-0577-7
35. DD Kurylo 2004 Effects of quinpirole on operant conditioning: perseveration of behavioral components Behav Brain Res 155 117 124 15325785 10.1016/j.bbr.2004.04.015 1:CAS:528:DC%2BD2cXmvFWktLk%3D (Pubitemid 39119972)
36. JV Leite FS Guimaraes FA Moreira 2008 Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychostimulants in mice Eur J Pharmacol 578 222 227 18021764 10.1016/j.ejphar.2007.09.016 1:CAS:528:DC%2BD1cXhsFahtQ%3D%3D (Pubitemid 350309581)
37. RTS McGowan CT Robbins JR Alldredge RC Newberry 2010 Contrafreeloading in grizzly bears: implications for captive foraging enrichment Zoo Biol 29 484 502 19816856
38. J Micallef O Blin 2001 Neurobiology and clinical pharmacology of obsessive-compulsive disorder Clin Neuropharmacol 24 191 207 11479390 10.1097/00002826-200107000-00002 1:STN:280:DC%2BD38%2FislKnsw%3D%3D (Pubitemid 32717853)
39. MS Milella D Amato A Badiani P Nencini 2008 The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat Psychopharmacology 197 379 390 18189126 10.1007/s00213-007-1044-0 1:CAS:528:DC%2BD1cXjsFOnu78%3D
40. MS Milella F Passarelli L De Carolis C Schepisi P Nativio S Scaccianoce P Nencini 2010 Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia Psychopharmacology (Berl) 211 355 366 10.1007/s00213-010-1909-5 1:CAS:528:DC%2BC3cXnsFKjsLg%3D
41. MJ Millan A Gobert F Lejeune A Newman-Tancredi JM Rivet A Auclair JL Peglion 2001 S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J Pharmacol Exp Ther 298 565 580 11454918 1:CAS:528:DC%2BD3MXlsVKqsLs%3D (Pubitemid 32673407)
42. RE Nordquist C Risterucci JL Moreau M von Kienlin B Kunnecke M Maco C Freichel C Riemer W Spooren 2008 Effects of Aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats Neuropharmacology 54 405 416 18054053 10.1016/j.neuropharm.2007.10.010 1:CAS:528:DC%2BD1cXpt1Kgug%3D%3D
43. PL Remijnse MMA Nielen AJLM van Balkom DC Cath P van Oppen HBM Uylings DJ Veltman 2006 Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder Arch Gen Psychiatry 63 1225 1236 17088503 10.1001/archpsyc.63.11.1225 (Pubitemid 44708081)
44. RD Rogers BJ Everitt A Baldacchino AJ Blackshaw R Swainson K Wynne NB Baker J Hunter T Carthy E Booker M London JFW Deakin BJ Sahakian TW Robbins 1999 Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanism Neuropsychopharmacology 20 322 339 10088133 10.1016/S0893-133X(98)00091-8 1:CAS:528:DyaK1MXitVSntbs%3D (Pubitemid 29099763)
45. RD Rogers EM Tunbridge Z Bhagwagar WC Drevets BJ Shakian CS Carter 2003 Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues Neuropsychopharmacology 28 153 162 12496952 10.1038/sj.npp.1300001 1:CAS:528:DC%2BD3sXhtlWitro%3D
46. JD Salamone M Correa 2002 Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine Behav Brain Res 137 3 25 12445713 10.1016/S0166-4328(02)00282-6 1:CAS:528:DC%2BD38Xoslanurw%3D (Pubitemid 35346426)
47. JD Salamone MS Cousins S Bucher 1994 Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure Behav Brain Res 65 221 229 7718155 10.1016/0166-4328(94)90108-2 1:CAS:528:DyaK2MXjvVOisro%3D
48. JD Salamone M Correa S Mingote S Weber 2003 Accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation and psychiatry J Pharmacol Exp Ther 305 1 8 12649346 10.1124/jpet.102.035063 1:CAS:528:DC%2BD3sXis1antLw%3D (Pubitemid 36373829)
49. JD Salamone M Correa A Farrar SM Mingote 2007 Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits Psychopharmacology 191 461 482 17225164 10.1007/s00213-006-0668-9 1:CAS:528:DC%2BD2sXitlCqurY%3D (Pubitemid 46355902)
50. DA Shapiro S Renock E Arrington LA Chiodo L Liu DR Sibley BL Roth R Mailman 2003 Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 1400 1411 12784105 10.1038/sj.npp.1300203 1:CAS:528:DC%2BD3sXls1Slsro%3D (Pubitemid 41070874)
51. PG Strange 2008 Antipsychotic drug action: antagonism, inverse agonism or partial agonism Trends Pharmacol Sci 29 314 321 18471899 10.1016/j.tips.2008. 03.009 1:CAS:528:DC%2BD1cXmvVymtrc%3D
52. H Szechtman E Woody 2004 Obsessive-compulsive disorder as disturbance of security motivation Psychol Rev 111 111 127 14756589 10.1037/0033-295X.111.1.111 (Pubitemid 38157078)
53. H Szechtman W Sulis D Eilam 1998 Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD) Behav Neurosci 112 1475 1485 9926830 10.1037/0735-7044.112.6.1475 1:CAS:528:DyaK1MXhsF2kt78%3D (Pubitemid 29052635)